PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942523F0262Prd-03565 APTIMA hiv-1 QUANT DX ASSAY — Gen-Probe Inc

Gen-Probe Inc holds $112.5M across 5,120 federal awards. This PIID sits alongside 3 related awards under parent W81XWH19A0008. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Aug 25, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Army Med Res Acq Activity

Awarding office

Gen-Probe Inc

Recipient

Aug 25, 2023

PoP end

$187K

Obligated

$187K

Potential

325413

NAICS

6550

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Gen-Probe Inc — $90

Contract facts

NONE

Contract numberHT942523F0262

Also listed asHT9425-23-F-0262

Also listed asW81XWH19A0008-HT942523F0262

AgencyArmy Med Res Acq Activity

Awarding officeArmy Med Res Acq Activity

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentGen-Probe Inc

CAGE0BDV3

UEIQNXWLAJDL4J3

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVW81XWH19A0008

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationHT942523Q0127

PoP startAug 25, 2023

PoP end (current)Aug 25, 2023

Obligated$187K

Current value$187K

Potential value$187K

PRD-03565, APTIMA HIV-1 QUANT DX ASSAY is a federal NONE award for Army Med Res Acq Activity held by Gen-Probe Inc. Estimated value $187K ($187K obligated). Current period of performance ends Aug 25, 2023. Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation HT942523Q0127.

Recompete timing

Public

● Past PoP end (1092 days ago)

Current PoP ended Aug 25, 2023 (1092 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Gen-Probe Inc — $112.5M obligated across 5,120 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$719K · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

W81K0222P0032

NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03…

$2.0M

Sep 30, 2026

N3239822P0303

EXERCISE OPTION YEAR 4 SERVICE AGREEMENT N3239822P0303 FOR: PANTHER FUSION (SN: 2090003912…

$122K

May 19, 2027

W81K0022P0111

KIT, APTIMA COMBO 2 CT/GC 250 TEST

$2.2M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT942523F0262?

HT942523F0262 (Prd-03565 APTIMA hiv-1 QUANT DX ASSAY) is a Army Med Res Acq Activity award with a potential value of $187K, currently held by Gen-Probe Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9425-23-F-0262?

HT9425-23-F-0262 is the dashed form of PIID HT942523F0262 (Prd-03565 APTIMA hiv-1 QUANT DX ASSAY), held by Gen-Probe Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT942523F0262?

Army Med Res Acq Activity awarded HT942523F0262 to Gen-Probe Inc (potential $187K).

Who is the incumbent on HT942523F0262?

Gen-Probe Inc is the incumbent with $112.5M across 5120 related awards in SCOUT’s public footprint. The current period of performance ends Aug 25, 2023.

When does Gen-Probe Inc’s HT942523F0262 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 25, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Aug 9, 2023